CAPA Best Practices for Small Manufacturers
Corrective and preventive actions don't have to be overwhelming. Here's how smaller teams can manage CAPA effectively.
Corrective and preventive action (CAPA) is one of the most frequently cited areas in FDA Warning Letters and ISO 13485 audit findings. For small manufacturers, the challenge is usually not understanding CAPA conceptually — it's implementing it consistently without a dedicated quality team.
Effective CAPA at small companies depends on right-sizing the process. Not every nonconformance requires a full root cause investigation. Define criteria for when a correction is sufficient versus when a full CAPA is warranted. Document that decision. Auditors want to see that you have a rational, consistent approach — not that every issue triggers the same heavyweight process.
Root cause analysis is where most small manufacturers struggle. Fishbone diagrams and 5-Why analyses are useful tools, but only when applied honestly. The goal is to identify the systemic cause, not to document that you looked. Once identified, effectiveness checks must be scheduled and completed — a CAPA that closes without verification is a finding waiting to happen.
Practical perspectives on regulatory compliance, quality systems, and navigating the medical device landscape.
Talk to a Compliance ExpertContinue Reading
More insights from our regulatory team
